Department of Anesthesiology, Klinik für Anästhesiologie, Klinikum der Ludwig-Maximilians-Universität (LMU), University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.
Department of Anesthesiology, Klinikum Konstanz, Constance, Germany.
Intensive Care Med. 2022 Sep;48(9):1165-1175. doi: 10.1007/s00134-022-06826-7. Epub 2022 Aug 11.
This case-control study investigated the long-term evolution of multidrug-resistant bacteria (MDRB) over a 5-year period associated with the use of selective oropharyngeal decontamination (SOD) in the intensive care unit (ICU). In addition, effects on health care-associated infections and ICU mortality were analysed.
We investigated patients undergoing mechanical ventilation > 48 h in 11 adult ICUs located at 3 campuses of a university hospital. Administrative, clinical, and microbiological data which were routinely recorded electronically served as the basis. We analysed differences in the rates and incidence densities (ID, cases per 1000 patient-days) of MDRB associated with SOD use in all patients and stratified by patient origin (outpatient or inpatient). After propensity score matching, health-care infections and ICU mortality were compared.
5034 patients were eligible for the study. 1694 patients were not given SOD. There were no differences in the incidence density of MDRB when SOD was used, except for more vancomycin-resistant Enterococcus faecium (0.72/1000 days vs. 0.31/1000 days, p < 0.01), and fewer ESBL-producing Klebsiella pneumoniae (0.22/1000 days vs. 0.56/1000 days, p < 0.01). After propensity score matching, SOD was associated with lower incidence rates of ventilator-associated pneumonia and death in the ICU but not with ICU-acquired bacteremia or urinary tract infection.
Comparisons of the ICU-acquired MDRB over a 5-year period revealed no differences in incidence density, except for lower rate of ESBL-producing Klebsiella pneumoniae and higher rate of vancomycin-resistant Enterococcus faecium with SOD. Incidence rates of ventilator-associated pneumonia and death in the ICU were lower in patients receiving SOD.
本病例对照研究调查了 5 年内与 ICU 选择性口腔去污(SOD)使用相关的多药耐药菌(MDRB)的长期演变。此外,还分析了对与医疗保健相关的感染和 ICU 死亡率的影响。
我们调查了在大学医院的 3 个校区的 11 个成人 ICU 中接受机械通气> 48 小时的患者。行政、临床和微生物学数据,这些数据都是通过电子方式常规记录的,作为基础。我们分析了所有患者和按患者来源(门诊或住院)分层的 SOD 使用与 MDRB 相关的发生率和发生率密度(ID,每 1000 患者天的病例数)之间的差异。在进行倾向评分匹配后,比较了医疗保健感染和 ICU 死亡率。
5034 名患者符合研究条件。1694 名患者未接受 SOD。当使用 SOD 时,MDRB 的发生率密度没有差异,除了万古霉素耐药粪肠球菌更多(0.72/1000 天与 0.31/1000 天,p < 0.01)和产 ESBL 肺炎克雷伯菌更少(0.22/1000 天与 0.56/1000 天,p < 0.01)。在进行倾向评分匹配后,SOD 与 ICU 获得性肺炎和 ICU 死亡的发生率较低相关,但与 ICU 获得性菌血症或尿路感染无关。
在 5 年内对 ICU 获得性 MDRB 的比较显示,除了产 ESBL 肺炎克雷伯菌的发生率较低和 SOD 中万古霉素耐药粪肠球菌的发生率较高外,发生率密度没有差异。接受 SOD 的患者 ICU 获得性肺炎和死亡的发生率较低。